Large Pharma Partner Halozyme Therapeutics Offers To Acquire ...

On Thursday, Halozyme Therapeutics, Inc. (NASDAQ:HALO) submitted a non-binding proposal to Evotec SE (NASDAQ:EVO) to acquire the German ...

Halozyme makes 2 billion euro buyout offer for drug developer Evotec

Halozyme Therapeutics said on Thursday it has proposed to buy German drug developer Evotec for about 2 billion euros ($2.10 billion), ...

Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D ...

Halozyme, a biotech firm whose drug delivery technology is a key component of biologic medicines marketed by several big pharma partners, ...

Halozyme sets out offer to acquire Evotec - The Pharma Letter

Shares of German drug discovery company Evotec leapt 20% to 10.33 euros this morning on the revelation that the USA's Halozyme Therapeutics ...

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per ...

With increased scale, a deep pipeline, and a diversified offering, we would be a highly attractive strategic partner to the biopharma industry.

Halozyme bids for Evotec; BeiGene gets a new name

Halozyme Therapeutics has made an unsolicited bid to buy drug discovery specialist Evotec for 11 euros per share in cash, an offer worth some 2 ...

Halozyme offers €11 per share to acquire Evotec for €2bn

Halozyme Therapeutics has submitted a non-binding proposal to acquire Evotec for €11 per share in cash, valuing the company at €2bn.

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per ...

Halozyme proposes to acquire Evotec for €11.00 per share, combining ENHANZE technology with Evotec's drug discovery platform to create a ...

Argenx widens its Halozyme Therapeutics-partnered net with 4 new ...

With a recently acquired FDA nod for its Halozyme Therapeutics-partnered Vyvgat Hytrulo, argenx is looking to take Halozyme's delivery tech ...

J&J, Roche partner Halozyme buys Antares Pharma for $1B, beefing ...

The acquisition adds on to Halozyme's Enhanze drug delivery technology, which allows intravenous therapies to be given under the skin by ...

Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA

Biotech stocks surged to a two-year high amid promising clinical developments, with Halozyme, United Therapeutics, Harmony, Ligand, ...

Halozyme to Acquire Antares Pharma to Create a Specialty Product ...

Halozyme Therapeutics, Inc. and Antares Pharma ... therapy launches, and partnerships. Business ... offer, Halozyme will acquire all remaining shares not ...

Halozyme Nears Deal to Buy Antares - Dow Jones

Shares of Antares Pharma rose in pre-market trading after Dow Jones Newswires reported Halyzome Therapeutics is near a deal to acquire the ...

Quarterly Results - Halozyme Therapeutics, Inc. - Financials

Amount relates to inventory write-off due to TLANDO Termination and amortization of the inventory step-up associated with purchase accounting for the prior year ...

San Diego's Halozyme Therapeutics to buy Antares Pharma for ...

San Diego's Halozyme Therapeutics, which provides technology to biopharmaceutical companies to help them develop treatments that are ...

Halozyme to Acquire Antares Pharma to Create a Specialty Product ...

Halozyme Therapeutics, Inc. and Antares Pharma ... therapy launches, and partnerships. Business ... offer, Halozyme will acquire all ...

Halozyme Buys Antares for $960M - San Diego Business Journal

In a deal showcasing Halozyme Therapeutics as an ongoing leader in drug ... Halozyme brings money, expertise and relationships with large pharma ...

Halozyme: How This Small Biotech Is Getting Under Your Skin

The company licenses its technology to Big Pharma and biotech companies and they use it to develop subcutaneous versions of their biggest IV ...

Halozyme Therapeutics to acquire Antares Pharma in all-cash deal

In a deal that will strengthen its emphasis on the delivery of drugs, Halozyme Therapeutics Inc. offered to acquire specialised ...

Halozyme, doubling down on a licensing strategy, buys a drug ...

Halozyme Therapeutics, a San Diego-based ... offerings through a nearly $1 billion acquisition of Antares Pharma. ... Quantiphi, DDReg Partner ...